Help | Staff Login

Committee Agendas Online

Carbon Reduction
  • Informational Meeting
    • Invited testimony only

    • Utilities
      Dave Robertson, Vice President, Public Policy, Portland General Electric
      Kevin Poloncarz, Covington & Burling LLP, for Calpine Corporation
      Kim Heiting, Senior Vice President of Utility Operations and Chief Marketing Officer, NW Natural
      Crystal Ball, Oregon Constituent Account Executive, Bonneville Power Administration
      Bob Jenks, Executive Director, Citizens Utility Board

    • Traded Sector Industries
      Kristen Sheeran, Energy and Climate Change Policy Advisor to Governor Kate Brown; Director, Carbon Policy
      Greg Alderson, Deputy Director, Carbon Policy Office
      Curtis Lesslie, Vice President, Environmental Affairs, Ash Grove Cement Company
      Chris McCabe, Executive Director, Northwest Pulp & Paper Association
      Pam Barrows, Vice President of Energy, Environment & Sustainability, Food Northwest
      Mike Smaha, Director, U.S. Government Affairs, Owens-Illinois
      Ryan Modlin, Vice President, North American Government Affairs, Owens-Illinois

    • Future Meeting Dates (subject to change)
      September 25, 2018, 12:00-2:00 PM (Legislative Days)
      November 8, 2018, 1:00-4:00 PM
      December 12-14, 2018 (Legislative Days, day and time TBA)

    • Note change: presenters' names have been added.

Task Force
Fair Pricing of Prescription Drugs
  • Informational Meeting
    • 10:00 - 10:10 AM Welcome, Agenda Review, Meeting Notes/Evaluation Summary, and Summary of Task Force Activities/Next Steps
      Dana Hargunani and Andrew Stolfi, Co-Chairs
      Sam Imperati, Facilitator

      10:10 - 10:30 AM Executive Summary on Transparency Survey
      Sam Imperati, Facilitator
      LPRO Staff

      10:30 - 12:00 PM University of Southern California (USC) Flow of Money in Pharmaceutical System Presentation and Discussion of Flow of Money Constructs
      Neeraj Sood, PhD, Vice Dean for Research, USC Sol Price School of Public Policy; Director of Research,
      USC Schaeffer Center
      Sam Imperati, Facilitator

      12:00 - 12:30 PM First Break (Lunch)

      12:30 - 2:00 PM Review and Finalize Cost Factors, Evaluation Criteria, Glossary, and Pharmaceutical Supply Chain Schematic
      Sam Imperati, Facilitator
      LPRO Staff

      2:00 - 2:15 PM Second Break

      2:15 - 2:45 PM Other States' Efforts on Transparency and Other Pharmaceutical Policy
      Sam Imperati, Facilitator
      LPRO Staff

      2:45 - 3:45 PM Brainstorm Proposals for Market Participants and Identified Cost Factors for the Task Force to Consider in September
      Dana Hargunani and Andrew Stolfi, Co-Chairs
      Sam Imperati, Facilitator

      3:45 - 3:55 PM Public Comment
      Sam Imperati, Facilitator

      3:55 - 4:00 PM Closing Comments, Next Steps, and Meeting Evaluation
      Dana Hargunani and Andrew Stolfi, Co-Chairs
      Sam Imperati, Facilitator

      4:00 PM Adjourn

    • Please note: the meeting time for the Joint Interim Task Force on Fair Pricing of Prescription Drugs has been changed to 8 AM - 2 PM.

    • This will be populated with a full agenda by September 20, 2018. Please take note of the date and time for the Task
      Force meeting.
Health Care Cost Review
  • Informational Meeting
    • 8:30 - 8:40 AM Welcome, Opening Remarks
      Zeke Smith, Interim Chair

      8:40 - 9:00 AM Public Comment
      Zeke Smith, Interim Chair

      9:00 - 9:40 AM Delaware Health Care Benchmark: Implementation Considerations
      Steven Costantino, Director of Health Care Reform and Financing, Delaware Health and Social Services

      9:45 - 11:00 AM Task Force Discussion - Health Care Cost Review
      Zeke Smith, Interim Chair
      Oliver Droppers, Task Force Staff
      Final Review of Proposed Recommendations
      Process for Reviewing and Approving Final Report
      Next Steps
  • Work Session
    • 11:00 - 11:30 AM Adoption of Report and Recommendations
      Zeke Smith, Interim Chair